Sonde Health, a voice-based monitoring technology company, raised $19.25 million in series B financing.
The company will use the financing to drive its global growth, deepen its respiratory and mental health monitoring technologies, and build capabilities for new health conditions. So far, the company has raised $35.25 million total, according to a Dec. 8 news Sonde news release.
Partners Investment led the financing round, with participation from Neom Company, KT Corp. and existing investors.
"Digital biomarkers are becoming a mainstay in healthcare. Today's healthcare companies are realizing how vocal biomarkers can engage people earlier in their health. The data and insights found in voice can power health monitoring and patient stratification so issues can become apparent well before a costly medical event occurs," Sonde CEO David Liu said. "With voice and any listening device, accessible and effective health monitoring can be made available to the majority of the world."